'Iii trials' diaporamas de présentation

534 views • 36 slides

Chapter 3 Introduction to Adjudications

350 views • 25 slides

Effective and Safe Blood Substitutes: An Attainable Reality or Lost Cause?

Effective and Safe Blood Substitutes: An Attainable Reality or Lost Cause?. Jonathan S. Jahr, MD Professor of Clinical Anesthesiology David Geffen School of Medicine at UCLA. Disclosure Statement. Hemosol Incorporated: Principle Investigator in two Phase II Trials, Speakers Bureau.

328 views • 13 slides

Activities for Physicians Visiting CTEP

CTEP Visiting Physician Externship Coordinator: Igor Espinoza-Delgado, M.D. NCI CTEP Investigational Drug Branch espinozaIg@mail.nih.gov. Activities for Physicians Visiting CTEP. Visiting physicians (VPs) are involved in the day to day operations of CTEP

168 views • 5 slides

Activities for Physicians Visiting CTEP

CTEP Visiting Physician Externship Coordinator: Igor Espinoza-Delgado, M.D. NCI CTEP Investigational Drug Branch espinozaIg@mail.nih.gov. Activities for Physicians Visiting CTEP. Visiting physicians (VPs) are involved in the day to day operations of CTEP

58 views • 5 slides